342 related articles for article (PubMed ID: 20938717)
21. Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion.
Gilder AS; Jones KA; Hu J; Wang L; Chen CC; Carter BS; Gonias SL
J Biol Chem; 2015 Jun; 290(24):14798-809. PubMed ID: 25837250
[TBL] [Abstract][Full Text] [Related]
22. Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61.
Young N; Pearl DK; Van Brocklyn JR
Mol Cancer Res; 2009 Jan; 7(1):23-32. PubMed ID: 19147534
[TBL] [Abstract][Full Text] [Related]
23. EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.
Roos A; Dhruv HD; Peng S; Inge LJ; Tuncali S; Pineda M; Millard N; Mayo Z; Eschbacher JM; Loftus JC; Winkles JA; Tran NL
Mol Cancer Res; 2018 Jul; 16(7):1185-1195. PubMed ID: 29724813
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity.
Rong Y; Belozerov VE; Tucker-Burden C; Chen G; Durden DL; Olson JJ; Van Meir EG; Mackman N; Brat DJ
Cancer Res; 2009 Mar; 69(6):2540-9. PubMed ID: 19276385
[TBL] [Abstract][Full Text] [Related]
25. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
[TBL] [Abstract][Full Text] [Related]
26. EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in Glioblastoma.
Blomquist MR; Eghlimi R; Beniwal A; Grief D; Nascari DG; Inge L; Sereduk CP; Tuncali S; Roos A; Inforzato H; Sharma R; Pirrotte P; Mehta S; Fortin Ensign SP; Loftus JC; Tran NL
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892466
[TBL] [Abstract][Full Text] [Related]
27. Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling.
Hu J; Muller KA; Furnari FB; Cavenee WK; VandenBerg SR; Gonias SL
Oncogene; 2015 Jul; 34(31):4078-88. PubMed ID: 25347738
[TBL] [Abstract][Full Text] [Related]
28. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
29. EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma.
Su L; Guo W; Lou L; Nie S; Zhang Q; Liu Y; Chang Y; Zhang X; Li Y; Shen H
Mol Carcinog; 2020 May; 59(5):520-532. PubMed ID: 32134157
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.
Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A
Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446
[TBL] [Abstract][Full Text] [Related]
31. Extracellular Hyaluronic Acid Influences the Efficacy of EGFR Tyrosine Kinase Inhibitors in a Biomaterial Model of Glioblastoma.
Pedron S; Hanselman JS; Schroeder MA; Sarkaria JN; Harley BAC
Adv Healthc Mater; 2017 Nov; 6(21):. PubMed ID: 28766870
[TBL] [Abstract][Full Text] [Related]
32. An EGFR wild type-EGFRvIII-HB-EGF feed-forward loop regulates the activation of EGFRvIII.
Li L; Chakraborty S; Yang CR; Hatanpaa KJ; Cipher DJ; Puliyappadamba VT; Rehman A; Jiwani AJ; Mickey B; Madden C; Raisanen J; Burma S; Saha D; Wang Z; Pingle SC; Kesari S; Boothman DA; Habib AA
Oncogene; 2014 Aug; 33(33):4253-64. PubMed ID: 24077285
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of sphingosine kinase 1 suppresses proliferation of glioma cells under hypoxia by attenuating activity of extracellular signal-regulated kinase.
Zhang H; Li W; Sun S; Yu S; Zhang M; Zou F
Cell Prolif; 2012 Apr; 45(2):167-75. PubMed ID: 22288844
[TBL] [Abstract][Full Text] [Related]
34. Guanylate binding protein-1 mediates EGFRvIII and promotes glioblastoma growth in vivo but not in vitro.
Lan Q; Wang A; Cheng Y; Mukasa A; Ma J; Hong L; Yu S; Sun L; Huang Q; Purow B; Li M
Oncotarget; 2016 Mar; 7(9):9680-91. PubMed ID: 26848767
[TBL] [Abstract][Full Text] [Related]
35. ZD6474, a multitargeted inhibitor for receptor tyrosine kinases, suppresses growth of gliomas expressing an epidermal growth factor receptor mutant, EGFRvIII, in the brain.
Yiin JJ; Hu B; Schornack PA; Sengar RS; Liu KW; Feng H; Lieberman FS; Chiou SH; Sarkaria JN; Wiener EC; Ma HI; Cheng SY
Mol Cancer Ther; 2010 Apr; 9(4):929-41. PubMed ID: 20371720
[TBL] [Abstract][Full Text] [Related]
36. SphK1/S1P Mediates PDGF-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation via miR-21/BMPRII/Id1 Signaling Pathway.
Li F; Wang J; Zhu Y; Liu L; Feng W; Shi W; Wang Q; Zhang Q; Chai L; Li M
Cell Physiol Biochem; 2018; 51(1):487-500. PubMed ID: 30453304
[TBL] [Abstract][Full Text] [Related]
37. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma.
Inda MM; Bonavia R; Mukasa A; Narita Y; Sah DW; Vandenberg S; Brennan C; Johns TG; Bachoo R; Hadwiger P; Tan P; Depinho RA; Cavenee W; Furnari F
Genes Dev; 2010 Aug; 24(16):1731-45. PubMed ID: 20713517
[TBL] [Abstract][Full Text] [Related]
38. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
[TBL] [Abstract][Full Text] [Related]
39. Blockade of glioma proliferation through allosteric inhibition of JAK2.
He K; Qi Q; Chan CB; Xiao G; Liu X; Tucker-Burden C; Wang L; Mao H; Lu X; McDonald FE; Luo H; Fan QW; Weiss WA; Sun SY; Brat DJ; Ye K
Sci Signal; 2013 Jul; 6(283):ra55. PubMed ID: 23838182
[TBL] [Abstract][Full Text] [Related]
40. LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
Int J Oncol; 2018 Sep; 53(3):1069-1082. PubMed ID: 30015847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
